Site Search

Share

X

Search Results

NJ Assembly Financial Institutions & Insurance Committee Votes to Improve Access to Biomarker Testing

... Financial Institutions & Insurance Committee voted to improve New Jerseyans’ access to biomarker testing, advancing Assembly Bill 4163 out of committee. Championed by Assemblymembers Shavonda Sumter, Gary Schaer and Shama Haider, the proposal would ensure biomarker testing is covered ... Senate. The following is a statement from Quinton Law, Government Relations Director for the American Cancer Society Cancer Action Network (ACS CAN) in New Jersey: "Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s individual condition. Over the past few months, we have heard countless stories of the challenges patients face in attempting to access this important testing. It’s time for that to change.” "This legislation addresses a ...

Proposal Aimed at Improving Health Outcomes for Mainers Secures Overwhelming Support from Voters

... Committee on Health Coverage, Insurance and Financial Services will consider LD 1577. The American Cancer Society Cancer Action Network (ACS CAN) urges Committee members to support the bill, which aims to expand coverage for biomarker testing—when medically appropriate—to Mainers insured through state-regulated health plans, including Medicaid.   Biomarker testing is a tool utilized by physicians across a variety of specialties to connect patients to the right treatment at the right time. It has become a game-changing part of cancer care by opening the door to targeted treatments that can lead to improved survivorship and quality of life. Despite the proven benefits ...

Cancer Survivors Thank New Mexico State Lawmakers for Passing Biomarker Testing Bill

SANTE FE – MARCH 20, 2023 – The American Cancer Society Cancer Action Network (ACS CAN) applauds members of the New Mexico State Legislature for passing House Bill 73 as the 2023 legislative session ended. With the signature of Governor Michelle Lujan Grisham, the bill will expand access to biomarker testing statewide, helping to revolutionize cancer care in New ...

Expand Access to Biomarker Testing in Delaware

Biomarker testing helps connect patients with the right treatment at the right time.  ACS CAN and partners are working together to make sure more Delaware residents can benefit from this important testing!  Video of maggies_biomarker_story   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, disease or abnormal function that can be measured in blood, tissue or bodily fluid.  Biomarker testing  is the ...

Expand Access to Biomarker Testing in Vermont

Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN and partners are working together to make sure more Vermont residents can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, disease or abnormal function that can be measured in blood, tissue or bodily fluid.  Biomarker testing is the analysis of a patient’s tissue, blood or other biospecimen for the presence of a biomarker.   Political action is needed to ensure more Vermont ...

Expand Access to Biomarker Testing in New Hampshire

Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN and partners are working together to make sure more New Hampshire residents can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, disease or abnormal function that can be measured in blood, tissue or bodily fluid.  Biomarker testing is the analysis of a patient’s tissue, blood or other biospecimen for the presence of a biomarker.   Political action is needed to ensure more Granite Staters ...

Expand Access to Biomarker Testing in Maine

Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN and partners are working together to make sure more Maine residents can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, disease or abnormal function that can be measured in blood, tissue or bodily fluid.  Biomarker testing is the analysis of a patient’s tissue, blood or other biospecimen for the presence of a biomarker.   Political action is needed to ensure more Maine ...

Maryland Lawmakers Overwhelmingly Support Increasing Access to Biomarker Testing

... 17, 2023 – Last week, HB 1217 / SB 805 landed on Governor Wes Moore’s desk following its near-unanimous passage in the Senate and House of Delegates and representing a victory for cancer patients across Maryland. The legislation aims to ensure biomarker testing is covered by all ... We are thrilled at the prospect of securing such progress for Marylanders.” Sen. Ellis continued, “This legislation will help dismantle cost barriers and bring the promise of precision medicine to cancer patients and survivors across Maryland, no matter their income, race or where they live.” “Hearing the three simple words ‘you have cancer’ can turn anyone’s world upside down. Progress in improving cancer outcomes increasingly involves the use of precision medicine which allows more ...

Calls to Improve New Yorkers’ Access to Precision Medicine Through Biomarker Testing Bring Together Patients and Providers from across Disease Spectrum

... to cover biomarker testing when it is supported by medical and scientific evidence. Over 60 organizations have rallied together in support of the legislation, citing the efficacy of and praising the innovation in precision medicine.  Biomarker testing is a tool utilized by physicians ... medicine, or personalized care. Biomarker testing helps providers to identify the most appropriate treatment for a disease. In cancer care, this can enable patients to receive targeted therapies and is often used in determining a patient’s eligibility for participation in clinical trials. ... care to the patients we serve, Northwell created a Center for Genomic Medicine to deliver these innovative approaches as rapidly and cost-effectively as possible, partnering expertise in cancer molecular diagnostics with oncology physicians to improve cancer outcomes in real ...

Maryland State Budget Produces Mixed Results in Fight against Cancer

Maryland state lawmakers have released details on the agreed upon 2025-26 budget—the contents of which are a mixed bag in the fight against cancer. While the state made sound investments in cancer research and protected Medicaid recipients’ ability to access biomarker testing, it missed an opportunity to save the lives and lungs of Maryland’s youth by cutting funding for the state’s tobacco prevention and cessation programs. To mark both the victories and missed opportunities, Lance Kilpatrick, government relations director for the American Cancer Society Cancer Action Network (ACS CAN) in Maryland, responded with the following statement: “With looming threats to cancer research funding in D.C. and so many lives hanging in ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy